× Cisplatin therapy and the problem of gender-related nephrotoxicity

× Biopsy series of acute kidney injury from a tertiary care referral center in south India

× Prevention of cisplatin nephrotoxicity

× Acute kidney injury due to ciprofloxacin for treatment of acute pyelonephritis

× Clinical profile of kidney involvement preceding diagnosis of multiple myeloma; a single center experience

× Manifestation of paroxysmal nocturnal hemoglobinuria as repeated acute kidney injury

× Proton-pump inhibitors and risk of renal disease

× Hospital-acquired nephrotoxic exposures in the precipitation of acute kidney injury – A case series analysis and a call for more preventative nephrology practices

× Proposed laboratory surrogate markers for the management of acute kidney injury in ethylene glycol poisoning in resource-challenged countries; a Mayo Clinic Health System, Wisconsin, case analysis

× Administration of metformin in clinical medicine; an updated mini-review on current findings 

× The demise of contrast nephropathy; can this be true? A contrarian view; a representative case report of contrast nephropathy from Mayo Clinic Health System in Northwestern Wisconsin

× Rituximab in ANCA-associated vasculitis presenting with severe acute kidney injury; a case report

× Pseudohypercalcemia in a patient with multiple myeloma and acute kidney injury; a case report

× Continuous renal replacement therapy in Iran; current practice, indications and outcomes in hemodynamically unstable patients

× Decongestive diuresis using combination intravenous loop diuretics plus chlorothiazide in type 1 acute cardiorenal syndrome and worsening acute kidney injury; a neglected paradigm in resource-poor settings

× Perspectives on the relationship of renal disease and coronavirus disease 2019

× Covid-19 and kidney; a mini-review on current concepts and new data

× Herbal antioxidants and renal ischemic-reperfusion injury; an updated review

× Comparison of urinary KIM-1 and NGAL and plasma creatinine in patients undergoing coronary artery bypass graft surgery

× Supportive treatment for cast nephropathy in patients with multiple myeloma; a pilot study

× Glomerulonephritis associated with SARS-CoV-2 infection

× The efficiency of remote ischemic preconditioning on serum cystatin C-based acute kidney injury in patients undergoing coronary angiography; a randomized controlled trial

× New hope for treatment of respiratory involvement following COVID-19 by bromhexine

× Metformin induced acute kidney injury; a systematic review

× Understanding kidney injury in COVID-19; a pressing priority

× Acute oxalate nephropathy associated with herbal remedies

× Crescentic glomerulonephritis in a man with a history of methamphetamine abuse; a possible cause for concern

× Kidney injury molecule-1; is it a predictive marker for renal diseases?

× Possible nephrotoxic effects of high dose statin therapy; current knowledge

× The association between hyperuricemia and the risk of acute kidney injury; a systematic review and meta-analysis

× Nephrotoxicity of checkpoint inhibitors; a current challenge

× Administration of N-acetylcysteine for contrast-induced acute kidney injury; an updated mini-review

× Prognosis and factors affecting mortality in patients with acute kidney injury due to cardiorenal syndrome type 1 treated with sustained low-efficiency dialysis

× Renal dysfunction after hematopoietic cell transplantation; a mini-review study

× Acute kidney injury following cancer immunotherapy; collaboration of oncologists and nephrologists

× Dengue fever-associated glomerulonephritis; an updated narrative mini-review

× Renoprotective efficacy of montelukast; an overview on recent advancements